James F. Reddoch

Insider Reports History

Location
New York, NY
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for James F. Reddoch
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James F. Reddoch:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Royalty Pharma plc EVP & Chief Scientific Officer Class A Ordinary Shares 821K $22.6M $27.55 28 Sep 2022 By Reddoch RPI LLC
Royalty Pharma plc EVP & Chief Scientific Officer Class A Ordinary Shares 25K $690K $27.55 28 Sep 2022 By IRA
Royalty Pharma plc EVP & Chief Scientific Officer LP interests in RPI US Partners 2019, LP 479K 12 Aug 2022 By Reddoch RPI LLC

Insider Reports Filed by James F. Reddoch

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RPRX Royalty Pharma plc 28 Sep 2022 2 -$4.12M 4 EVP & Chief Scientific Officer 30 Sep 2022, 16:23
RPRX Royalty Pharma plc 08 Jun 2022 1 -$4.16M 4 EVP & Chief Scientific Officer 10 Jun 2022, 17:13
RPRX Royalty Pharma plc 27 May 2022 1 -$3.08M 4 EVP & Chief Scientific Officer 31 May 2022, 17:23
RPRX Royalty Pharma plc 19 May 2022 1 -$3.03M 4 EVP & Chief Scientific Officer 23 May 2022, 16:57
RPRX Royalty Pharma plc 10 Sep 2021 1 $0 4 EVP, Research & Investments 30 Dec 2021, 17:03
RPRX Royalty Pharma plc 26 Jul 2021 1 -$356K 4 EVP, Research & Investments 27 Jul 2021, 17:25
RPRX Royalty Pharma plc 26 Jul 2021 1 -$356K 4 EVP, Research & Investments 27 Jul 2021, 17:23
RPRX Royalty Pharma plc 12 Jul 2021 3 -$753K 4 EVP, Research & Investments 14 Jul 2021, 17:17
RPRX Royalty Pharma plc 06 Jul 2021 3 -$3.09M 4 EVP, Research & Investments 08 Jul 2021, 19:37
RPRX Royalty Pharma plc 04 Jun 2021 4 -$9.11M 4 EVP, Research & Investments 08 Jun 2021, 20:12
RPRX Royalty Pharma plc 02 Jun 2021 1 -$2.11M 4 EVP, Research & Investments 04 Jun 2021, 18:50
RPRX Royalty Pharma plc 07 May 2021 2 $0 4 EVP, Research & Investments 11 May 2021, 21:06